Investing in Atrion Corporation (ATRI)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)160.76-64
Intrinsic value (DCF)183.67-59
Graham-Dodd Method270.74-40
Graham Formula58.64-87

Company description

Atrion Corporation, traded under the ticker ATRI, is a healthcare company that specializes in developing and producing medical devices and components for the healthcare industry. Established in 1944, Atrion has a long history of providing innovative solutions for its customers. With a focus on cardiac, fluid delivery, and ophthalmology markets, the company has a diverse portfolio of products ranging from surgical tools to fluid delivery systems. Atrion has established itself as a leader in its industry by consistently meeting the demands of its customers and maintaining a high standard of quality in its products. The company's commitment to research and development has resulted in numerous patents and continued growth. Atrion also places a strong emphasis on corporate responsibility, actively supporting charitable organizations and environmental sustainability initiatives. As a publicly traded company, Atrion has experienced steady financial growth and is positioned for further expansion in the healthcare market. Overall, Atrion Corporation stands as a reputable, innovative, and socially responsible company in the healthcare industry.